Frequently Asked Questions

What is a microbial context?

What kind of data is needed?

Does Discovery replace abundance analysis?

Does Discovery measure microbial activity?

Is Discovery just functional annotation?

What is a microbiome digital twin?

How is this different from biomarker analysis?

What makes the models explainable?

What data do we need?

How are proposed mechanisms validated?

Can we use Minutia Twin to simulate trials?

Does the FDA recognise these approaches?